Abstract

The strong antibacterial, antiviral and anticancer activities demonstrated by quinolones make them promising lead structures and important synthetic targets for drug discovery. Here, we report, to the best of our knowledge, the first scalable total synthesis of antiviral (+)-aniduquinolone A, possessing a 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one skeleton. This synthetic strategy explores E-stereoselective Horner–Wadsworth–Emmons (HWE) olefination as the key step to assemble isopropenyl substituted tetrahydrofuran onto the 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one core, which is built by highly diastereoselective intramolecular aldol reaction. Moreover, two sets of stereoisomers of aniduquinolone A with substantially overlapping NMR data were synthesized completely and assigned unambiguously by comprehensive analysis of both their spectroscopic and X-ray diffraction data. Unexpectedly, aflaquinolones A, C, and D that feature different 2,4-dimethyl cyclohexanone moieties were transformed successfully from (+)-aniduquinolone A by treating with TFA. The methodology delineated herein can be applied broadly to the synthesis of natural alkaloids containing the core structure of 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one.

Quinolones can possess desirable antibacterial, antiviral and anticancer properties, rending them important synthetic targets for drug discovery purposes. Here, the gram-scale total synthesis of antiviral (+)-aniduquinolone A, possessing a 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one skeleton, is reported, as well as its acid-catalyzed rearrangement to aflaquinolones A, C, and D.

Details

Title
Scalable total synthesis of (+)-aniduquinolone A and its acid-catalyzed rearrangement to aflaquinolones
Author
Feng-Wei, Guo 1 ; Xiao-Feng, Mou 2 ; Qu Yong 1 ; Mei-Yan, Wei 3 ; Chen Guang-Ying 4 ; Chang-Yun, Wang 1 ; Yu-Cheng, Gu 5   VIAFID ORCID Logo  ; Chang-Lun, Shao 1   VIAFID ORCID Logo 

 Ocean University of China, Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Qingdao, China (GRID:grid.4422.0) (ISNI:0000 0001 2152 3263); Pilot National Laboratory for Marine Science and Technology (Qingdao), Laboratory for Marine Drugs and Bioproducts, Qingdao, China (GRID:grid.484590.4) (ISNI:0000 0004 5998 3072) 
 Ocean University of China, Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Qingdao, China (GRID:grid.4422.0) (ISNI:0000 0001 2152 3263); Yantai University, School of Pharmacy, Yantai, China (GRID:grid.440761.0) (ISNI:0000 0000 9030 0162) 
 Ocean University of China, Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Qingdao, China (GRID:grid.4422.0) (ISNI:0000 0001 2152 3263) 
 Hainan Normal University, College of Chemistry and Chemical Engineering, Haikou, China (GRID:grid.440732.6) (ISNI:0000 0000 8551 5345) 
 Syngenta Jealott’s Hill International Research Centre, Bracknell, UK (GRID:grid.426114.4) (ISNI:0000 0000 9974 7390) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993669
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2640575165
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.